24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Merck
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
16:00
Wix acquires Hour One, accelerating its push into AI-powered digital experiences
17:33
Full list of Israeli startup M&As in 2025
17:24
Fortinet acquires Israeli cyber startup Suridata for tens of millions to boost SaaS protection
17:03
Full list of Israeli high-tech funding rounds in 2025
More stories
Buzz
Most popular
Daily
Weekly
1
Fortinet acquires Israeli cyber startup Suridata for tens of millions to boost SaaS protection
2
Wix acquires Hour One, accelerating its push into AI-powered digital experiences
3
Gigi Levy-Weiss and Redis co-founder Yiftach Shoolman launch defense tech startup Line 5, raising $20M Seed round
4
Intel considering selling off networking business in strategic overhaul
5
Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive
More news
Merck
5 stories about Merck
Biolojic Design lands drug discovery collaboration with Merck potentially worth up to 346 million euros
03.06.24
|
Sophie Shulman
The partnership will leverage Biolojic Design’s AI-driven discovery platform to design therapeutic antibodies for the treatment of cancer and immunological disorders.
Pharma giant Merck expands collaboration with Quris-AI
28.09.23
|
Meir Orbach
This follows the successful initial collaboration, a preclinical study to assess Quris-AI’s ability to predict drug toxicity in comparison to traditional in vitro and in vivo approaches
Israeli biotech phenom puts death knell on cancer
21.05.23
|
Roni Dori
At 44, Gal Markel is a biotech bulldozer. After a $95 million exit, the professor of immunology serves as the Deputy Director General of Beilinson Hospital and the Director of the Davidoff Cancer Center, and is also involved in five startups. Now he has raised around $33 million to establish the Samueli Institute, researching ways to help the immune system eradicate cancer cells
“Pharma companies need to capitalize on early-stage breakthrough innovation.”
29.11.22
|
CTech
Collaboration is key for pharmaceutical companies as they seek to make the drug development process more efficient and successful, says Larisa Amir, managing director of Merck’s R&D Center.
Larisa Amir appointed Managing Director of Merck R&D Center in Israel
13.06.22
|
CTech
Amir will be responsible for managing the center and will also focus on in-house innovation and external scouting for technologies and biotechnology capabilities in Israeli startups, academia, and hospitals
